Europe — EMA
Paclitaxel Accord Healthcare Ireland
Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Ireland, is a taxane chemotherapy agent presented as a sterile powder for intravenous infusion use.
Request sourcing
What is Paclitaxel?
Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Ireland, is a taxane chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered under the supervision of oncology specialists.
GNH USA supplies Paclitaxel Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Paclitaxel used for?
Paclitaxel is a chemotherapy drug that interferes - Breast cancer: improves im - Ovarian cancer: helps - Non‑small cell lung cancer: contributes to tumour shrinkage and disease control.
What are the side effects of Paclitaxel?
The …
Product details
Related products

Paclitaxel 100 mg/20mL
Paclitaxel · 100 mg/20 mL

PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg/20mL
Paclitaxel · 100 mg/20 mL

Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL

Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL